鍾啟禮(Chung, Chi-Li)　教授

Email
clchung@tmu.edu.tw
現   職
呼吸治療學系 教授

學經歷

學　歷

畢業學校與學位[修業時間]
台北醫學大學臨床醫學研究所 博士
2003/08/01~2008/01/01
臺北醫學大學醫學研究所 碩士
2001/09/01~2003/06/01
臺北醫學大學醫學系 學士
1982/09/01~1989/06/01

本校學術經歷

任職單位與職稱[起迄時間]
呼吸治療學系教授
2020/02/01~
呼吸治療學系副教授
2013/08/01~2020/01/31
呼吸治療學系助理教授
2008/08/01~2013/07/31

本校兼職教學行政經歷

服務單位與職稱[起迄時間]
藥理學科副教授
2019/11/01 ~
內科學科副教授
2016/08/01 ~

其它經歷

任職單位與職稱[起迄時間]
台北醫學大學附設醫院胸腔內科主治醫師
1997/02~
臺北榮民總醫院胸腔部住院醫師
1991/08~1997/02

專長與研究領域

學門領域
胸腔內科
Chest
學術專長
Chest Medicine
Chest Medicine
ELISA, Western blot, RT-PCR

論文著作

清冊下載

論文 Journal Paper


1. 2023 Chen WL,Lee KL,Lai KS,Tsai JH,Hsiao SH,Chung CL. Toll-like Receptor 2 Mediates VEGF Overexpression and Mesothelial Hyperpermeability in Tuberculous Pleural Effusion . International Journal of Molecular Sciences .2023 ;(24):2846-2846

2. 2023 Ho CB,Tsai JT,Chen CY,Shiah HS,Chen HY,Ting LL, Kuo CC, Lai IC, Lai HY, Chung CL, Lee KL, Tzeng HE, Lee KH, Lee HL, Chen SW, Chiou JF. Effectiveness of Stereotactic Ablative Radiotherapy for Systemic Therapy Respondents with Inoperable Pulmonary Oligometastases and Oligoprogression . diagnostics .2023

3. 2023 Hsiao SH,Sue YM,Kao CC,Chang HW,Lin YC,Hung CS, Hsieh YC, Hong SY, Chung CL, Chang JH, Su YS, Liu MC, Lai KS, Chien KL, Wang JC, Cheng CY, Fang TC. Comparison of Humoral Antibody Responses and Seroconversion Rates between Two Homologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination in Patients Undergoing Maintenance Hemodialysis . Vaccines (Basel) .2023

4. 2023 Lee KL,Lai TC,Lee WJ,Chen YC,Ho KH,Hung WY, Yang YC, Chan MH, Hsieh FK, Chung CL, Chang JH, Chien MH. Sustaining the Activation of EGFR Signal by Inflammatory Cytokine IL17A Prompts Cell Proliferation and EGFR-TKI Resistance in Lung Cancer . Cancers (Basel) .2023

5. 2023 Tran HM ,Lin YC,Tsai FJ,Lee KY,Chang JH,Chung CL, Chung KF, Chuang KJ, Chuang HC. Short-term mediating effects of PM2.5 on climate-associated COPD severity . Science of The Total Environment .2023

6. 2023 Lu KJ,Sheu JR,Teng RD,Jayakumar T,Chung CL,Hsieh CY. Ability of Local Clearance of Senescent Cells in Ipsilateral Hemisphere to Mitigate Acute Ischemic Brain Injury in Mice . International Journal of Biological Sciences .2023

7. 2022 Huang WC,Hou SM,Wu MP,Hsia CW,Jayakumar T,Hsia CH, Bhavan PS, Chung CL, Sheu JR. Decreased Human Platelet Activation and Mouse Pulmonary Thrombosis by Rutaecarpine and Comparison of the Relative Effectiveness with BAY11-7082: Crucial Signals of p38-NF-κB . Molecules .2022 ;(27):476-476

8. 2022 Chung CL*,Chen JH,Huang WC,Sheu JR*,Hsia CW,Jayakumar T, Hsia CH, Chiou KR, Hou SM. Glabridin, a bioactive flavonoid from licorice, effectively inhibits platelet activation in humans and mice. . Int J Mol Sci .2022 ;(23):11372-11372

9. 2021 Hung WY,Lee WJ,Cheng GZ,Tsai CH,Yang YC,Lai TC, Chen JQ, Chung CL, Chang JH, Chien MH. Blocking MMP-12-modulated epithelial-mesenchymal transition by repurposing penfluridol restrains lung adenocarcinoma metastasis via uPA/uPAR/TGF-β/Akt pathway. . Cellular Oncology .2021 ;(44):1087-1103

10. 2021 Jayakumar T,Wu MP,Sheu JR,Hsia CW,Bhavan PS,Manubolu M, Chung CL, Hsia CH. Involvement of Antioxidant Defenses and NF-κB/ERK Signaling in Anti-Inflammatory Effects of Pterostilbene, a Natural Analogue of Resveratrol . Applied Sciences .2021 ;(11):4666-4666

11. 2021 Chen WL,Chen MC,Hsu SF,Hsiao SH,Chung CL. HDAC Inhibitor Abrogates LTA-Induced PAI-1 Expression in Pleural Mesothelial Cells and Attenuates Experimental Pleural Fibrosis . Pharmaceuticals .2021 ;(14):585-585

12. 2020 Chung CL,Lin YS,Chan NJ,Chen YY,Hsu CC. Hypersensitivity of Airway Reflexes Induced by Hydrogen Sulfide: Role of TRPA1 Receptors . Int. J. Mol. Sci. .2020 ;(21):3929-3929

13. 2020 Hsia CW,Wu MP,Shen MY,Hsia CH,Chung CL,Sheu JR. Regulation of Human Platelet Activation and Prevention of Arterial Thrombosis in Mice by Auraptene through Inhibition of NF-kB Pathway . Int. J. of Mol. Sci. .2020 ;(21):4810-4810

14. 2020 Lee HL,Chiou JF,Wang PY,Lu LS,Shen CN,Hsu HL, Burnouf T, Ting LL, Chou PC, Chung CL, Lee KL, Shiah HS, Liu YL, Chen YJ.. Ex vivo expansion and drug sensitivity profiling of circulating tumor cells from patients with small cell lung cancer . Cancers .2020 ;(12):3394-3394

15. 2019 Lin CS,Chen CY,Yeh CC,Chung CL,Chen TL,Liao CC. Defining risk of general surgery in patients with chronic obstructive pulmonary diseases . QJM .2019 ;(112)

16. 2019 Wu ZH,Tsai JH,Hsieh CY,Chen WL,Chung CL. Endothelin-1 Induces Mesothelial Mesenchymal Transition and Correlates with Pleural Fibrosis in Tuberculous Pleural Effusions . J Clin Med .2019 ;(8):E426

17. 2019 Lien JC*,Chung CL*,Huang TF,Chang TC,Chen KC,Gao GY, Hsu MJ, Huang SW. A novel 2‐aminobenzimidazole‐based compound Jzu 17 exhibits anti‐angiogenesis effects by targeting VEGFR‐2 signalling . British Journal of Pharmacology .2019 ;(176):4034-4049

18. 2019 Hsieh CY,Sheu JR,Yang CH,Chen WL,Tsai JH,Chung CL. Thrombin Upregulates PAI-1 and Mesothelial–Mesenchymal Transition Through PAR-1 and Contribute to Tuberculous Pleural Fibrosis. . Int J Mol Sci .2019 ;(20):E5076-E5076

19. 2018 Lee KL,Chen WL,Chen RJ,Lai KS,Chung CL. Lipoteichoic acid upregulates plasminogen activator inhibitor-1 expression in parapneumonic effusions . Respirology .2018 ;(23):89-95

20. 2018 Liu WC,Lin CS,Yeh CC,Wu HY,Lee YJ,Chung CL, Cherng YG, Chen TL, Liao CC. Effect of influenza vaccination against postoperative pneumonia and mortality for geriatric patients receiving major surgery: a nationwide matched study. . J Infect Dis .2018 ;(217):816-826

21. 2018 Hsia CH,Jayakumar T,Sheu JR,Tsao SY,Velusamy M,Hsia CW, Chou DS, Chang CC, Chung CL, Khamrang T, Lin KC. Structure-Antiplatelet Activity Relationships of Novel Ruthenium (II) Complexes: Investigation of Its Molecular Targets . Molecules .2018 ;(23):E477-E477

22. 2018 Yen TL,Chang CC,Chung CL,Ko WC,Yang CH,Hsieh CY. Neuroprotective Effects of Platonin, a Therapeutic Immunomodulating Medicine, on Traumatic Brain Injury in Mice after Controlled Cortical Impact . Int J Mol Sci .2018 ;(19):pii: E1100

23. 2018 Chang CC,Chen TL,Lin CS,Chung CL,Yeh CC,Hu CJ, Lane HL, Liao CC, Shih CC. Decreased risk of pneumonia in stroke patients receiving acupuncture: A nationwide matched-pair retrospective cohort study . PLoS One .2018 ;(13):e0196094

24. 2018 Hsia CW,Wu MP,Velusamy M,Hsia CH,Chou DS,Tsai CL, Hsu CY, Jayakumar T, Chung CL, Sheu JR. Novel Therapeutic Agent against Platelet Activation In Vitro and Arterial Thrombosis In Vivo by Morin Hydrate . Int J Mol Sci .2018 ;(19):E2386-E2386

25. 2018 Lu WJ,Chung CL,Chen RJ,Huang LT,Lien LM,Chang CC, Lin KH, Sheu JR. An Antithrombotic Strategy by Targeting Phospholipase D in Human Platelets . J Clin Med .2018 ;(7):pii: E440

26. 2018 Wu MP,Chang NC,Chung CL,Chiu WC,Hsu CC,Chen HM, Sheu JR, Jayakumar T, Chou DS, Fong TH.. Analysis of Titin in Red and White Muscles: Crucial Role on Muscle Contractions Using a Fish Model . Biomed Res Int. .2018 ;(2018)

27. 2017 Lin CS,Shih CC ,Yeh CC,Hu CJ,Chung CL,Chen TL, Liao CC. Risk of stroke and post-stroke adverse events in patients with exacerbations of chronic obstructive pulmonary disease . PLoS One .2017 ;(12)

28. 2017 Kao SJ,Lee WJ,Chang JH ,Chow JM ,Chung CL ,Hung WY, Chien MH.. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer . Environmental Toxicology .2017 ;(32):1426-1438

29. 2017 Hsiao SH,Chou YT,Lin SE,Hsu RC,Chung CL ,Kao YR, Liu HE, Wu CW. Brain metastases in patients with non-small cell lung cancer: the role of mutated-EGFRs with an exon 19 deletion or L858R point mutation in cancer cell dissemination. . Oncotarget .2017 ;(8):53405-53418

30. 2017 Lin CS,Liu CC,Yeh CC,Chang YC,Chung CL ,Lane HL, Shih CC, Chen TL, Liao CC.. Diabetes risks and outcomes in chronic obstructive pulmonary disease patients: Two nationwide population-based retrospective cohort studies . PLoS One .2017 ;(12):e0181815-e0181815

31. 2016 Lin CS,Chang CC,Yeh CC,Chung CL,Chen TL,Liao CC. Postoperative Adverse Outcomes in Patients With Asthma: A Nationwide Population-based Cohort Study. . Medicine .2016 ;(95):e2548

32. 2016 Yen TL,Wu MP,Chung CL,Yang WB,Jayakumar T,Geraldine P, Chou CM, Chang CY, Lu WJ, Sheu JR. Novel synthetic benzimidazole-derived oligosaccharide, M3BIM, prevents ex vivo platelet aggregation and in vivo thromboembolism . Journal of Biomedical Science .2016 ;(23):26

33. 2015 Bien MY,Wu MP,Chen WL,Chung CL. VEGF Correlates with Inflammation and Fibrosis in Tuberculous Pleural Effusion. . Scientific World Journal .2015 ;(2015):417124

34. 2015 Lin HW*,Chung CL*,Lin YS,Yu CM,Lee CN,Bien MY. Inhaled Pharmacotherapy and Stroke Risk in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population Based Study Using Two-Stage Approach. . PLoS ONE .2015 ;(10):e01301

35. 2015 Chung CL,Leung KW,Lu WJ,Yen TL,He CF,Sheu JR, Lin KH, Lien LM. Hinokitiol negatively regulates immune responses through cell cycle arrest in concanavalin A-activated lymphocytes. . Evid Based Complement Alternat Med .2015 ;(2015):595824

36. 2015 Ke CC,Lin CS,Yeh CC,Chung CL,Hung CJ,Liao CC, Chen TL. Adverse Outcomes after Non-Chest Surgeries in Patients with Pulmonary Tuberculosis: A Nationwide Study. . PLoS ONE .2015 ;(10):e13306

37. 2015 Chen WL,Sheu JR,Chen RJ,Hsiao SH,Hsiao CJ,Chou YC, Chung CL*, Hsiao G*. Mycobacterium tuberculosis upregulates TNF-α expression via TLR2/ERK signaling and induces MMP-1 and MMP-9 production in human pleural mesothelial cells. . PLoS ONE .2015 ;(10):e01379

38. 2014 Chen WL,Sheu JR,Hsaio CJ,Hsiao SH,Chung CL,Hsiao G. Histone Deacetylase Inhibitor Impairs Plasminogen Activator Inhibitor-1 Expression via Inhibiting TNF-α-Activated MAPK/AP-1 Signaling Cascade. . BioMed Res Int (formerly J Biomed Biotechnol) .2014 ;(2014):1-9

39. 2014 Hsiao CJ,Hsaio G,Chen WL,Wang SW,Chiang CP,Liu LY, Guh JH, Lee TH, Chung CL. Cephalochromin Induces G0/G1 Cell Cycle Arrest and Apoptosis in A549 Human Non-Small-Cell Lung Cancer Cells by InflictingMitochondrial Disruption . J Nat Prod .2014 ;(77):758-765

40. 2014 Lien LM,Chen ZC,Chung CL,Yen TL,Chiu HC,Chou DS, Huang SY, Sheu JR, Lu WJ, Lin KH.. Multidrug resistance protein 4 (MRP4/ABCC4) regulates thrombus formation in vitro and in vivo. . Eur J Pharmacol .2014 ;(737):159-167

41. 2013 Chung CL,Hsiao SH,Hsiao G,Sheu JR,Chen WL,Chang SC. Clinical Importance of Angiogenic Cytokines, Fibrinolytic Activity and Effusion Size in Parapneumonic Effusions . PLOS ONE .2013 ;(8):e53169

42. 2013 Chang Y,Huang SK,Lu WJ,Chung CL,Chen WL,Lu SH, Lin KH, Sheu JR. Brazilin isolated from Caesalpinia sappan L. acts as a novel collagen receptor agonist in human platelets. . Journal of Biomedical Science .2013 ;(20):1-11

43. 2013 Lin KH,Kuo JR,Lu WJ,Chung CL,Chou DS,Huang SY, Lee HC, Sheu JR. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo . Biochemical Pharmacology .2013 ;(85):1478-1485

44. 2013 Hsiao SH,Lin HC,Chou YT,Lin SE,Kuo CC,Yu MC, Chung CL. Impact of epidermal growth factor receptor mutations on intracranial treatment response and survival after brain metastases in lung adenocarcinoma patients . Lung Cancer .2013 ;(81):455-461

45. 2013 Hsiao SH,Chung CL,Chou YT,Lee HL,Lin SE,Liu HE. Identification of subgroup patients with stage IIIB/IV non-small cell lung cancer at higher risk for brain metastases. . Lung Cancer .2013 ;(82):319-323

46. 2013 Hsiao SH,Chung CL,Lee CM,Chen WY,Chou YT,WU ZH, Chen YC, Lin SE. Suitability of computed tomography-guided biopsy specimens for subtyping and genotyping of non-small-cell lung cancer. . Clinical Lung Cancer .2013 ;(14):719-725

47. 2013 Hsiao SH,Liu HE,Lee HL,Lin CL,Chen WY,Wu ZH, Lin SE, Chiang LL, Chung CL. Distinct clinical outcomes of non-small cell lung cancer patients with epidermal growth factor receptor (EGFR) mutations treated with egfr tyrosine kinase inhibitors: non-responders versus responders. . PLoS One .2013 ;(8):e83266-e83266

48. 2012 Chung CL,Sheu JR,Chen WL,Chou YC,Hsiao CJ,Hsiao SH, Hsu MJ, Cheng YW, Hsiao G.. Histone deacetylase inhibitor m-carboxycinnamic bis-hydroxamide acid attenuates plasminogen activator inhibitor-1 expression in human pleural mesothelial cells. . Am J Respir Cell Mol Biol 2012 Apr;46(4):437-45 .2012 ;(46):437-445

49. 2012 Lee WR,Chung CL,Hsiao CJ,Chou YC,Hsueh PJ,Yang PC, Jan JS, Cheng YW, Hsiao G.. Suppression of matrix metalloproteinase-9 expression by andrographolide in human monocytic THP-1 cells via inhibition of NF-κB activation. . Phytomedicine 2012 Feb 15;19(3-4):270-7. .2012 ;(19):270-277

50. 2012 Hsiao CJ,Hsiao SH,Chen WL,Guh JH,Hsiao G,Chan YJ, Lee TH, Chung CL.. Pycnidione, a fungus-derived agent, induces cell cycle arrest and apoptosis in A549 human lung cancer cells. . Chem Biol Interact. 2012 Apr 15;197(1):23-30. .2012 ;(197):23-30

51. 2011 Chou YC,Sheu JR,Chung CL,Hsiao CJ,Hsueh PJ,Hsiao G. Hypertonicity-enhanced TNF-α release from activated human monocytic THP-1 cells requires ERK activation. . Biochimica et Biophysica Acta (BBA) – General Subjects .2011 ;(1810):475-484

52. 2010 Chen WL,Chung CL,Hsiao SH,Chang SC. Pleural space elastance and changes in oxygenation after therapeutic thoracentesis in ventilated patients with heart failure and transudative pleural effusions . Respirology .2010 ;(15):1001-1008

53. 2010 Chou YC,Sheu JR,Chung CL,Chen CY,Lin FL,Hsu MJ, Kuo YH, Hsiao G. Nuclear-targeted inhibition of NF-κB on MMP-9 production by N-2-(4-bromophenyl) ethyl caffeamide in human monocytic cells. . Chem-Biol Interact .2010 ;(184):403-412

54. 2010 Lee YJ,Liu HY,Lin YC,Sun KL,Chung CL,Hsueh PR. Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use. . Int J Antimicrobial Agents .2010 ;(33):469-472

55. 2010 Wu ZH,Chung CL. Pseudo-meigs’ syndrome presenting as lymphocytic pleural effusion with elevated adenosine deaminase activity – a case report. . Thorac Med .2010 ;(25):44-50

56. 2009 Tai CJ,Hsu CH,Wang FJ,Chau WK,Chung CL,Hsieh CC. Weekly Cetuximab and Gemcitabine plus Cisplatin as Salvage Therapy for Unresectable . Onkologie .2009 ;(32):685-686

57. 2009 Chung CL,Sheu JR,Liu HE,Chang SC,Chou YC,Chen WL, Hsiao G. Dynasore, a dynamin inhibitor, induces PAI-1 expression in MeT-5A human pleural mesothelial cells . Am J Resp Cell Mol Biol .2009 ;(40):692-700

58. 2009 Dai HY,Chen CL,Chung CL,Wang FC. Organizing pneumonia induced by low-dose short-duration amiodarone therapy-a case report . Thoracic Medicine .2009 ;(24):339-345

59. 2008 Chung CL,Chen CH,Yeh CY,Sheu JR,Chang SC. Early effective drainage in the treatment of loculated tuberculous pleuritis. . Eur Respir J .2008 ;(31):1261-1267

60. 2007 You YF,Lien YC,Fang CL,Chung CL. Mediastinal mature cystic teratoma presenting as a painful neck swelling – a case report. . Thorac Med .2007 ;(22):416-421

61. 2007 Chung CL,Yeh CY,Sheu JR,Chen YC,Chang SC. Repeated thoracenteses affect proinflammatory cytokine, vascular endothelial growth factor and fibrinolytic activity in pleural transudates. . Am J Med Sci .2007 ;(334):452-457

62. 2005 Chung CL,Chen CH,Sheu JR,Chen YC,Chang SC. Proinflammatory cytokines, transforming growth factor-β1 and fibrinolytic enzymes in loculated and free-flowing pleural exudates. . Chest .2005 ;(128):690-697

63. 2005 Lin HC,Kao SY,Wen HC,Wu CS,Chung CL. Length of stay and costs for asthma patients by hospital characteristics: A five-year population-based analysis. . J Asthma .2005 ;(42):537-542

64. 2004 Chen CH,Chung CL,Fang CL,Chen RF. Multiple Sclerosing Hemangiomas of the lung with lymph node metastasis – a case report. . Thorac Med .2004 ;(19):157-161

65. 2004 Chung CL,Chang SC. Effect of repeated thoracenteses on the fibrinolytic activity in malignant pleural effusion. . Chest .2004 ;(125):1965-1966

66. 2003 Chung CL,Chen YC,Chang SC. Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion. . Chest .2003 ;(123):1188-1195

67. 2001 Chang CC,Chung CL,Huang CL,Wang FC. Legionnaires’ disease in a patient with rheumatoid arthritis. . J Microbiol Immunol Infect .2001 ;(34):76-78

68. 1999 Sheu JJ,Yuan RY,Lu JJ,Chung CL,Hsu CY. Tuberculous meningitis in a Filipino maid. . J Formos Med Assoc .1999 ;(98):783-786

69. 1996 Chung CL,Perng RP. Thymic cyst: a case report. . Clin Med .1996 ;(37):63-64

70. 1995 Chung CL,Shao KM,Perng RP. Secondary pulmonary lymphoma: a case report. . Clin Med .1995 ;(35):191-194

會議論文 Conference Paper


1. 2016 Chung CL,Chen WL,Lee KL. Thrombin Correlates With Inflammation And Fibrosis In Infectious Pleural Effusions . American Journal of Respiratory and Critical Care Medicine .2016 ;(193)

2. 2016 Lipoteichoic Acid Upregulates Plasminogen Activator Inhibitor-1 Expression In Human Pleural Mesothelial Cells Via Tlr2/JNK/ap-1 Pathway . American Journal of Respiratory and Critical Care Medicine .2016 ;(193)

3. 2013 Chung CL,Chen WL,Hsiao SH,Hsiao G. Endothelin-1 in Inflammatory and Malignant Pleural Effusions . Chest .2013 ;(144):516A

4. 2011 Chung CL,Hsiao SH,Chen WL,Chang SC. Angiogenic cytokines and fibrinolytic activity in parapneumonic effusions. . Am J Respir Crit Care Med .2011 ;(183):A2360

5. 2010 Chung CL,Chen WL,Sheu JR,Hsiao CJ,Hsiao G. CBHA, histone deacetylase inhibitor, inhibited PAI-1 protein expression in human pleural mesothelial cell . 第25屆生物醫學聯合學術年會(99年度) .2010

6. 2010 Chung CL,Chen WL,Sheu JR,Hsiao G. Histone deacetylase inhibitor CBHA attenuates the expression of plasminogen activator inhibitor-1 in human pleural mesothelial cells. . Thorax .2010 ;(65):A105-A106

7. 2009 Chung CL,Chen WL,Hsiao SH,Chang SC. Changes in pleural pressure and gas exchange after therapeutic thoracentesis in mechanically ventilated heart failure patients with transudative pleural effusions. . APSR 2009, Seoul, the 14th congress of Asian Pacific Society of Respirology (APSR) .2009

8. 2008 Chung CL,Sheu JR,Liu HE,Chou YC,Chen WL,Hsiao G. Dynasore, a cell-permeable dynamin inhibitor, enhances transforming growth factor-β1-induced plasminogen activator inbibitor-1 expression in MeT-5A human pleural mesothelial cells. . 第23屆生物醫學聯合學術年會(97年度) .2008

9. 2008 Chung CL,Chen CH,Yeh CY,Sheu JR,Chang SC. Early effective drainage in the treatment of loculated tuberculous pleuritis. . ATS 2008, Toronto, the 103th annual international conference of American Thoracic Society (ATS) .2008

10. 2006 Chung CL,Yeh CY,Sheu JR,Chen YC,Chang SC. Fibrinogenesis induced by repeated thoracenteses in pleural transudates. . Chest 2006, the 72th annual international scientific assembly of the American College of Chest Physicians (ACCP) .2006

11. 2004 Chung CL,Chen CH,Chen YC,Chang SC. Proinflammatory cytokines, transforming growth factor-β1 and fibrinolytic enzymes in loculated and free-flowing pleural exudates. . ATS 2004 Orlando, the 99th annual international conference of American Thoracic Society (ATS) .2004

12. 2002 Chung CL,Chen YC,Chang SC. Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion. . Chest 2002, the 68th annual international scientific assembly of the American College of Chest Physicians (ACCP) .2002

研究計畫

計畫名稱
112 TRIM5調控肋膜間皮細胞的間皮間質轉形和細胞遷移於特發性肺纖維化的影響機轉
補助單位
國家科學及技術委員會
計畫名稱
111 吳茱萸次鹼對抑制大腦血管內皮細胞發炎以及血管平滑肌細胞增生的機轉探討及效價評估
補助單位
奇美醫療財團法人奇美醫院
計畫名稱
111 Glyoxalase 1 基因控制對肺癌惡性肋膜積水中代謝壓力介導產生的細胞上皮間質轉化與癌轉移的影響機轉(3/3)
補助單位
國家科學及技術委員會
計畫名稱
111 (呼吸治療學系鍾啟禮教授)延攬莊雨凡君參與「Glyoxa lase 1 基因控制對肺癌惡性肋膜積水中代謝壓力介導產生的細胞上皮間質轉化與癌轉移的影響機轉」研究計畫案，申請本會補助，業經核定以「博士級研究人員」資格補助(NSTC 111- 2811-B-038-041)
補助單位
國家科學及技術委員會
計畫名稱
110 Glyoxalase 1 基因控制對肺癌惡性肋膜積水中代謝壓力介導產生的細胞上皮間質轉化與癌轉移的影響機轉(2/3)
補助單位
科技部
計畫名稱
110 延攬科技人才蔡杰亨君參與「Glyoxalase 1 基因控制對肺癌惡性肋膜積水中代謝壓力介導產生的細胞上皮間質轉化與癌轉移的影響機轉」
補助單位
科技部
計畫名稱
109 Columbianadin的抗發炎治療：對NF-κB/ MAPKs訊息傳遞路徑和氧化壓力的影響
補助單位
奇美醫療財團法人奇美醫院
計畫名稱
109 Glyoxalase 1 基因控制對肺癌惡性肋膜積水中代謝壓力介導產生的細胞上皮間質轉化與癌轉移的影響機轉(1/3)
補助單位
科技部
計畫名稱
109 呼吸治療學系鍾啟禮副教授申請補助延攬科技人才蔡杰亨君參與「Glyoxalase 1 基因控制對肺癌惡性肋膜積水中代謝壓力介導產生的細胞上皮間質轉化與癌轉移的影響機轉」
補助單位
科技部
計畫名稱
107 革蘭氏陰性菌內毒素脂多醣體引起淋巴管內皮細胞凋亡、自體吞噬及細胞壞死之訊息傳遞作用
補助單位
奇美醫療財團法人奇美醫院
計畫名稱
107 結核性肋膜積水併發胸膜增厚之代謝體學分析研究
補助單位
科技部
計畫名稱
106 最新純化的多醣體 CME-1 抑制內毒素誘發巨噬細胞活化的分子機轉探討
補助單位
奇美醫療財團法人奇美醫院
計畫名稱
106 Thrombin於發炎性肋膜積水誘發纖維化過程中第一型胞漿素原活化抑制劑參與調控機轉之研究(2/2)
補助單位
科技部
計畫名稱
106 博後-KUMAR
補助單位
科技部
計畫名稱
105 baicalein 在敗血症引起小鼠心肌功能障礙之機轉探討
補助單位
奇美醫療財團法人奇美醫院
計畫名稱
105 Thrombin於發炎性肋膜積水誘發纖維化過程中第一型胞漿素原活化抑制劑參與調控機轉之研究(1/2)
補助單位
科技部
計畫名稱
105 Thrombin於發炎性肋膜積水誘發纖維化過程中第一型胞漿素原活化抑制劑參與調控機轉之研究(1/2)
補助單位
計畫名稱
105 Thrombin於發炎性肋膜積水誘發纖維化過程中第一型胞漿素原活化抑制劑參與調控機轉之研究-黃愈涵
補助單位
科技部
計畫名稱
105 呼吸治療學系申請補助延攬科技人才蔡杰亨先生參與「Thrombin於發炎性肋膜積水誘發纖維化過程中第一型胞漿素原活化抑制劑參與調控機轉之研究」研究計畫案，業經核定以「博士後研究」補助
補助單位
科技部
計畫名稱
104 蝦紅素透過增加淋巴球細胞中的interferon-γ和 interleukin-2進而刺激免疫反應
補助單位
奇美醫療財團法人奇美醫院
計畫名稱
104 第一型胞漿素原於thrombin誘導的肺肋膜發炎及纖維化扮演之角色
補助單位
臺北醫學大學附設醫院
計畫名稱
104 腫瘤壞死因子-α引發肺迷走感覺神經過度敏感的機轉
補助單位
臺北醫學大學附設醫院
計畫名稱
103 Hinokitiol抑制T-淋巴球細胞活化之作用機轉探討
補助單位
奇美醫療財團法人奇美醫院
計畫名稱
103 ENDOTHELIN-1對助膜間皮細胞轉形為肌纖維母細胞過程的影響及其促成助膜及肺纖維化之機轉-KUMAR
補助單位
科技部
計畫名稱
103 Endothelin-1對肋膜間皮細胞轉形為肌纖維母細胞過程的影響及其促成肋膜及肺纖維化之機轉(3/3)
補助單位
行政院國家科學委員會
計畫名稱
102 新NF-κB抑制劑andrographolide對於血管平滑肌細胞增生與腦血管內皮細胞功能失效的作用機轉探討
補助單位
奇美醫療財團法人奇美醫院
計畫名稱
102 Endothelin-1對肋膜間皮細胞轉形為肌纖維母細胞過程的影響及其促成肋膜及肺纖維化之機轉(2/3)
補助單位
行政院國家科學委員會
計畫名稱
102 ENDOTHELIN-1對肋膜間皮細胞轉形為肌纖維母細胞過程的影響及其促成肋膜及肺纖維化之機轉(2/3)
補助單位
科技部
計畫名稱
102 ENDOTHELIN-1對肋膜間皮細胞轉形為肌纖維母細胞過程的影響及其促成肋膜及肺纖維化之機轉(3/3)
補助單位
科技部
計畫名稱
102 ENDOTHELIN-1對肋膜間皮細胞轉形為肌纖維母細胞過程的影響及其促成肋膜及肺纖維化之機轉-林承輝
補助單位
科技部
計畫名稱
101 穿心蓮活性成分andrographolide引起腦血管內皮細胞凋亡及對腦缺血/再灌流引起腦損傷之機轉探討
補助單位
奇美醫療財團法人奇美醫院
計畫名稱
101 Endothelin-1對肋膜間皮細胞轉形為肌纖維母細胞過程的影響及其促成肋膜及肺纖維化之機轉
補助單位
行政院國家科學委員會
計畫名稱
100 Ketamine抑制大鼠平滑肌細胞增生之機轉探討
補助單位
奇美醫療財團法人奇美醫院
計畫名稱
100 探討組蛋白去乙醯酵素在促纖維化與促發炎細胞激素刺激肋膜間皮細胞誘發纖維化機轉中表基因調控的角色並以動物模式評估其標的抑制對肋膜纖維化的影響
補助單位
行政院國家科學委員會
計畫名稱
99 內吞訊息傳遞對於促纖維化及血管新生細胞激素活性的調控及肋膜纖維化的影響
補助單位
行政院國家科學委員會
計畫名稱
98 內吞訊息傳遞對於促纖維化及血管新生細胞激素活性的調控及肋膜纖維化的影響
補助單位
行政院國家科學委員會